Paid Clinical Trials in New Jersey

New Jersey has 1,790 paid clinical trials enrolling now across cities including New Brunswick, Hackensack and Basking Ridge. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 10, 2026.

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

1,790 clinical trials

↓ Download CSV

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

for Recurrent Squamous Cell Carcinoma

25 locations incl. Gilbert

Sponsor: Alpha Tau Medical LTD.

Sex: All·Age: 18+

Code: NCT05323253·Recruiting

Apply to this trial

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for Relapsed or Refractory Multiple Myeloma

Drug: Mezigdomide

56 locations incl. Los Alamitos

Sponsor: Celgene

Sex: All·Age: 18+

Code: NCT05519085·Phase 3·Recruiting

Apply to this trial

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

for Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

17 locations incl. Tampa

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05172245·Phase 1·Recruiting

Apply to this trial

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

for Cardiac Toxicity

10 locations incl. Elizabeth

Sponsor: Rutgers, The State University of New Jersey

Sex: Female·Age: 18+

Code: NCT05559164·Phase 2·Recruiting

Apply to this trial

Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence

for Cryptogenic Stroke

1 location in Camden

Sponsor: The Cooper Health System

Sex: All·Age: 18+

Code: NCT06398366·Enrolling By Invitation

Reducing Pain From Wisdom Molar Extractions

for Acute Pain

1 location in Newark

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18 - 64

Code: NCT05335070·Phase 2·Recruiting

Apply to this trial

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

for Locoregional Recurrence

Drug: Ribociclib

20 locations incl. Birmingham

Sponsor: Oana Danciu

Sex: All·Age: 18+

Code: NCT05467891·Phase 2·Recruiting

Apply to this trial

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

for Low Risk Myelodysplastic Syndromes

15 locations incl. Los Angeles

Sponsor: Rigel Pharmaceuticals

Sex: All·Age: 18+

Code: NCT05308264·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

for Head and Neck Cancer

6 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05544136·Phase 2·Recruiting

Apply to this trial

IVIG vs SCIG in CIDP

for CIDP

1 location in New Brunswick

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18 - 65

Code: NCT05584631·Phase 1·Recruiting

Apply to this trial

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for Endometrial Cancer

18 locations incl. Los Angeles

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05489211·Phase 2·Recruiting

Apply to this trial

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

for Oligometastatic Breast Carcinoma

8 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05534438·Phase 2·Recruiting

Apply to this trial

TVMR With the INNOVALVE System Trial - Early Feasibility Study

for Mitral Valve Regurgitation (Degenerative or Functional)

20 locations incl. Los Angeles

Sponsor: Edwards Lifesciences

Sex: All·Age: 18+

Code: NCT04919980·Recruiting

Apply to this trial

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

16 locations incl. Los Angeles

Sponsor: ModernaTX, Inc.

Sex: All·Age: 12+

Code: NCT05533697·Phase 1, Phase 2·Recruiting

Apply to this trial

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

for Advanced Cancer

7 locations incl. Phoenix

Sponsor: Qurient Co., Ltd.

Sex: All·Age: 18+

Code: NCT05394103·Phase 1, Phase 2·Recruiting

Apply to this trial

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for Endometrial Adenocarcinoma

69 locations incl. Mobile

Sponsor: Acrivon Therapeutics

Sex: Female·Age: 18+

Code: NCT05548296·Phase 2·Recruiting

Apply to this trial

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

for Coagulation Disorder

13 locations incl. Arkansas City

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT05156983·Phase 3·Recruiting

Apply to this trial

Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial

for Pneumonia

14 locations incl. Phoenix

Sponsor: University of Utah

Sex: All·Age: Up to 18

Code: NCT05471908·Recruiting

Apply to this trial

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

for Dermatitis Atopic

Drug: Amlitelimab

96 locations incl. Birmingham

Sponsor: Sanofi

Sex: All·Age: 12+

Code: NCT05492578·Phase 2, Phase 3·Enrolling By Invitation

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

for Acute Lymphoblastic Leukemia

746 locations incl. Anchorage

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 40 - 75·Accepts healthy volunteers

Code: NCT05334069·Recruiting

Apply to this trial

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

for Open Angle Glaucoma

15 locations incl. Newport Beach

Sponsor: Iantrek, Inc.

Sex: All·Age: 21+

Code: NCT05506423·Enrolling By Invitation

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

for Obstructive Hypertrophic Cardiomyopathy

Drug: Mavacamten

62 locations incl. Anchorage

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT05489705·Recruiting

Apply to this trial

Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA

for Antibiotic Prophylaxis

1 location in Morristown

Sponsor: Atlantic Health System

Sex: Female·Age: 18+·Accepts healthy volunteers

Code: NCT05519072·Phase 4·Recruiting

Apply to this trial

MiSight 1 Day Safety Post-Approval Study

for Myopia

47 locations incl. Gilbert

Sponsor: CooperVision, Inc.

Sex: All·Age: 8 - 12·Accepts healthy volunteers

Code: NCT05285527·Recruiting

Apply to this trial

A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

for Lymphoma, Non-Hodgkin

14 locations incl. Duarte

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05421663·Phase 1, Phase 2·Recruiting

Apply to this trial

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

for Anal Melanoma

Drug: Cabozantinib

143 locations incl. Auburn

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05111574·Phase 2·Recruiting

Apply to this trial

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for Breast Cancer

51 locations incl. Mobile

Sponsor: Greenwich LifeSciences, Inc.

Sex: All·Age: 18 - 100

Code: NCT05232916·Phase 3·Recruiting

Apply to this trial

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for Embryonal Rhabdomyosarcoma

165 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 21

Code: NCT05304585·Phase 3·Recruiting

Apply to this trial

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

for HPV

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05491512·Phase 2·Recruiting

Apply to this trial

The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial

for Extubation Failure

17 locations incl. Little Rock

Sponsor: University of Pennsylvania

Sex: All·Age: 0 Days - 9 Weeks

Code: NCT05446272·Recruiting

Apply to this trial

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

for Glioma

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05489783·Recruiting

Apply to this trial

Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma

for Carcinoma, Hepatocellular

2 locations incl. New Brunswick

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18+

Code: NCT05366829·Phase 2·Recruiting

Apply to this trial

A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)

for Mucopolysaccharidosis II

8 locations incl. Oakland

Sponsor: Denali Therapeutics Inc.

Sex: All·Age: 2 - 25

Code: NCT05371613·Phase 2, Phase 3·Recruiting

Apply to this trial

Safety and Effectiveness of the HIT Reverse HRS

for Degenerative Joint Disease

6 locations incl. Miami

Sponsor: Hip Innovation Technology

Sex: All·Age: 50 - 75

Code: NCT05357378·Recruiting

Apply to this trial

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

for Follicular Lymphoma

Drug: Mosunetuzumab

3 locations incl. New Haven

Sponsor: Brown University

Sex: All·Age: 18+

Code: NCT04792502·Phase 2·Recruiting

Apply to this trial

TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)

for Small Cell Lung Cancer

11 locations incl. Los Alamitos

Sponsor: Tempus AI

Sex: All·Age: 18+

Code: NCT05257551·Recruiting

Apply to this trial

sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)

for Gastro-Intestinal Cancer

6 locations incl. Hamilton

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18+

Code: NCT05332002·Phase 2·Recruiting

Apply to this trial

The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)

for HPV-positive Oropharyngeal Squamous Cell Carcinoma

2 locations incl. Paramus

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All·Age: 18+

Code: NCT05419089·Phase 2·Recruiting

Apply to this trial

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

for Stage III Colon Cancer

1021 locations incl. Birmingham

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT05174169·Phase 2, Phase 3·Recruiting

Apply to this trial

Validation Digital Bio-markers During Sulforaphane Treatment.

for Autism

1 location in Piscataway

Sponsor: Rutgers, The State University of New Jersey

Sex: Male·Age: 13 - 30

Code: NCT04805957·Enrolling By Invitation